Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Operating Margin (2019 - 2023)

Historic Operating Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 249.42%.

  • ADC Therapeutics' Operating Margin fell 2453400.0% to 249.42% in Q3 2023 from the same period last year, while for Sep 2023 it was 15.5%, marking a year-over-year increase of 448734300.0%. This contributed to the annual value of 2.36% for FY2022, which is 7740100.0% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Operating Margin is 249.42%, which was down 2453400.0% from 15666.65% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Operating Margin registered a high of 15666.65% during Q2 2023, and its lowest value of 439583174.87% during Q3 2021.
  • Over the past 5 years, ADC Therapeutics' median Operating Margin value was 260.48% (recorded in 2023), while the average stood at 31399289.46%.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2021, then soared by 2000000000bps in 2022.
  • Over the past 5 years, ADC Therapeutics' Operating Margin (Quarter) stood at 16095.5% in 2019, then skyrocketed by 100bps to 36.16% in 2020, then plummeted by -1215754084bps to 439583174.87% in 2021, then skyrocketed by 100bps to 15.38% in 2022, then tumbled by -1521bps to 249.42% in 2023.
  • Its last three reported values are 249.42% in Q3 2023, 15666.65% for Q2 2023, and 271.55% during Q1 2023.